Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Men and women ≥ 18 years old~2. Informed consent~3. Beneficiaries of a social security plan~4. Vaccinated or unvaccinated against SARS-COV-2:~   * Vaccinated individuals have had a 3rd dose for at least one month, or have been infected with SARS-Cov-2 and have had 2 doses of vaccine for at least one month~  * Unvaccinated persons are naïve to previous SARS Cov 2 infection~5. Positive nasopharyngeal RT-PCR test for selection with a Ct viral load ≤ 23~6. Have a phone and internet connection to access the entry application~Exclusion Criteria:~1. The participant is related to any member of the study staff or has a close relationship or conflict of interest with the sponsor.~2. Known hypersensitivity or allergy to any component of the test product.~3. Contraindication to nasal spray~4. Insufficient vaccination: any incomplete vaccination schedule~   * either a 3rd dose within the last month~  * or SARS-Cov-2 infection with less than 2 vaccine doses or with 2 vaccine doses less than 1 month old.~5. Any condition, including COVID, that is likely to result in hospitalization during study participation.~6. Conditions that may result in hospitalization during study participation.~7. Known pregnancy or positive urine pregnancy test at D0 by the nurse, or current breastfeeding~8. Participation in an antiviral clinical trial or other trial using a medical device for disease prevention COVID 19

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Advanced Water S-100 ionized nasal spray (Type: EXPERIMENTAL): 2 sprays in each nostril, 6 times a day during 8 days
- Nasal spray with purified water (Type: PLACEBO_COMPARATOR): 2 sprays in each nostril, 6 times a day during 8 days

Based on this trial design, predict the completion outcome and termination type (if applicable).